SICAGEN INDIA LTD. - 533014 - Compliance Certificate Under Reg 40(9) Of The SEBI (LODR) Regulations For The Half Year Ended 31 March 2019
A copy of compliance certificate issued by Practicing Company Secretary under Reg 40(9) of the SEBI (LODR) Regulations for the half year ended 31 March 2019 is attached for your records. Sicagen India Ltd - 533014 - Compliance Certificate For The Half Year Ended 31 March 2019
Compliance Certificate as required under Reg 7(3) of SEBI LODR Regulations for the half year ended 31 March 2019 is attached for your records. SICAGEN INDIA LTD. - 533014 - Shareholding for the Period Ended March 31, 2019
Sicagen India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here Sicagen India Ltd - 533014 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1001 Name of the Signatory :- G ArunmozhiDesignation :- Company Secretary and Compliance Officer Sicagen India Ltd - 533014 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Sicagen India Ltd Ltd has submitted to BSE a copy of Clarification is enclosed. Sicagen India Ltd - 533014 - Additional Investment In Wholly Owned Subsidiary Company Wilson Cables Private Ltd, Singapore
The Company has made additional investment to the extent of SGD 1,000,000/- (Singapore dollar one million only) in the equity capital of Wholly Owned Subsidiary Company namely Wilson Cable Private Limited, Singapore. The remittance of aforesaid investment amount to Wilson Cables has been completed today. Sicagen India Ltd - 533014 - Clarification Sought on Price Movement
The Exchange has sought clarification from Sicagen India Ltd on March 07, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. SICAGEN INDIA LTD. - 533014 - Approval Of The Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December,2018.
Approval the Un-audited financial results(both Standalone and consolidated) for the quarter and nine months ended 31st December,2018 along with the Limited Review Report. SICAGEN INDIA LTD. - 533014 - Shareholding for the Period Ended December 31, 2018
Sicagen India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here SICAGEN INDIA LTD. - 533014 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 3241 Name of the Signatory :- G ArunmozhiDesignation :- Company Secretary and Compliance Officer